799 related articles for article (PubMed ID: 18411229)
1. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
2. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
Nagareddy PR; McNeill JH; MacLeod KM
Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective iNOS inhibition on systemic hemodynamics and mortality rate on endotoxic shock in streptozotocin-induced diabetic rats.
Kadoi Y; Goto F
Shock; 2007 Nov; 28(5):602-9. PubMed ID: 17607161
[TBL] [Abstract][Full Text] [Related]
4. Diabetes-induced increased oxidative stress in cardiomyocytes is sustained by a positive feedback loop involving Rho kinase and PKCβ2.
Soliman H; Gador A; Lu YH; Lin G; Bankar G; MacLeod KM
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H989-H1000. PubMed ID: 22865386
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
Smith JM; Paulson DJ; Romano FD
J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
[TBL] [Abstract][Full Text] [Related]
7. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
8. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats.
Malyshev E; Tazi KA; Moreau R; Lebrec D
J Gastroenterol Hepatol; 2007 Dec; 22(12):2195-201. PubMed ID: 18031380
[TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase depresses cardiac contractile function in Zucker diabetic fatty rats.
Song D; Kuo KH; Yao R; Hutchings SR; Pang CC
Eur J Pharmacol; 2008 Jan; 579(1-3):253-9. PubMed ID: 17976576
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway.
Hunter JC; Zeidan A; Javadov S; Kilić A; Rajapurohitam V; Karmazyn M
J Mol Cell Cardiol; 2009 Dec; 47(6):810-8. PubMed ID: 19799911
[TBL] [Abstract][Full Text] [Related]
11. Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-beta.
Maggi A; Cignarella A; Brusadelli A; Bolego C; Pinna C; Puglisi L
Circulation; 2003 Jul; 108(2):211-7. PubMed ID: 12821541
[TBL] [Abstract][Full Text] [Related]
12. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
Amour J; Loyer X; Le Guen M; Mabrouk N; David JS; Camors E; Carusio N; Vivien B; Andriantsitohaina R; Heymes C; Riou B
Anesthesiology; 2007 Sep; 107(3):452-60. PubMed ID: 17721248
[TBL] [Abstract][Full Text] [Related]
13. Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia.
Gupta A; Sharma AC
Shock; 2003 Oct; 20(4):375-81. PubMed ID: 14501953
[TBL] [Abstract][Full Text] [Related]
14. Decreased RhoA expression in myocardium of diabetic rats.
Tang J; Fitzgerald SM; Boughtman BN; Cole SW; Brands MW; Zhang JH
Can J Physiol Pharmacol; 2005; 83(8-9):775-83. PubMed ID: 16333379
[TBL] [Abstract][Full Text] [Related]
15. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts.
Tatsumi T; Akashi K; Keira N; Matoba S; Mano A; Shiraishi J; Yamanaka S; Kobara M; Hibino N; Hosokawa S; Asayama J; Fushiki S; Fliss H; Nakagawa M; Matsubara H
J Mol Cell Cardiol; 2004 Sep; 37(3):775-84. PubMed ID: 15350850
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide production by hepatocytes contributes to the inhibitory effect of endotoxin on insulin-like growth factor I gene expression.
Priego T; Granado M; Castillero E; Martín AI; Villanúa MA; López-Calderón A
J Endocrinol; 2006 Sep; 190(3):847-56. PubMed ID: 17003285
[TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide produced by constitutive and inducible nitric oxide synthases in the mouse gastric fundus.
Arab HA; Hassanpour H; Bozorgi A
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1038-42. PubMed ID: 18505451
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.
Obasanjo-Blackshire K; Mesquita R; Jabr RI; Molkentin JD; Hart SL; Marber MS; Xia Y; Heads RJ
Cardiovasc Res; 2006 Sep; 71(4):672-83. PubMed ID: 16828070
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes.
Cheng X; Cheng XS; Kuo KH; Pang CC
Cardiovasc Res; 2004 Nov; 64(2):298-307. PubMed ID: 15485689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
